ISRCTN17262711已完成不适用
A randomised controlled trial comparing medical versus surgical termination of pregnancy at 13 - 20 weeks
ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 130 人开始时间: 2010年4月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Women accepted for termination of pregnancy (TOP) under clause C of the Human Fertilisation and Embryology Act (1990) amendment of the Abortion Act (1967)
- •2. Pregnancies between 13+0 and 19+6 weeks' gestation at the time of abortion
- •3. Aged over 16 years; women under 16 years of age were eligible for inclusion if deemed Fraser competent by the clinical practitioner and where a parent or guardian was present and also willing to give written consent
排除标准
- •1. Foetal congenital abnormality
- •2. Medical disease precluding MTOP
- •3. Unable to speak English (less than 5% of women presenting for TOP)
研究者
相似试验
已完成
不适用
A randomised controlled clinical trial comparing aesthetic arch wires and nickel titanium arch wires in initial alignmentOral Health: OrthodonticsOral HealthOrthodonticsISRCTN75477546Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)80
招募中
不适用
Evaluation of a telehealth intervention for delivering psychological support to people with brain tumour and their familiesDepressionAnxietyACTRN12618001737224Griffith University148
已完成
不适用
A randomised controlled trial comparing the clinical and cost-effectiveness of the Avaulta anterior mesh and the standard anterior colporraphy for the primary surgical treatment of a cystocele stage >= 2vaginal prolapsecystocele10029903NL-OMON30439niversitair Medisch Centrum Utrecht115
已完成
不适用
Evaluation of the role of an artificial intelligence system (iDA) in embryo selection.Reproductive Health and Childbirth - Fertility including in vitro fertilisationInfertilityACTRN12620000197932Vitrolife1,066
进行中（未招募）
Unknown
Evaluation of the role of Lymphadenectomy In high-risk Prostate cancer SurgEryBiopsy-proven clinically localised high-risk prostate cancerCancerISRCTN14434966Cardiff and Vale University Health Board1,080